Thanks for the confirmation.
Thanks! Joyce
Joyce Niejako
Grants & Contracts Specialist
Office for Sponsored Programs
University of Connecticut
Phone: 860-486-8798 Fax: 860-486-3726
>-----Original Message-----
>From: Research Administration List
>[mailto:xxxxxx@hrinet.org] On Behalf Of Wilson, Thomas
>Sent: Thursday, December 21, 2006 12:47 PM
>To: xxxxxx@hrinet.org
>Subject: Re: [RESADM-L] AIDS R01's
>
>They will not become electronic until after the R01 mechanism goes
>electronic on February 5, 2007. After that point all R01 submissions
>will be accepted only through Grants.gov on the 424R&R.
>
>Tom Wilson
>
>Thomas E. Wilson, MBA
>Director, Sponsored Projects
>City of Hope National Medical Center
> and Beckman Research Institute
>1500 East Duarte Road
>Duarte, CA 91010-3000
>
>Tel: 626-301-8438
>Fax: 626-301-8843
>
>
>-----Original Message-----
>From: Research Administration List [mailto:xxxxxx@hrinet.org] On
>Behalf Of Niejako, Joyce
>Sent: Thursday, December 21, 2006 9:34 AM
>To: xxxxxx@hrinet.org
>Subject: [RESADM-L] AIDS R01's
>
>Please assure me that AIDS R01's are still paper for the Jan. 2
>submission?
>
>Thanks! Joyce
>
>Joyce Niejako
>Grants & Contracts Specialist
>Office for Sponsored Programs
>University of Connecticut
>Phone: 860-486-8798 Fax: 860-486-3726
>
>
>======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
>subscription information and a web-searchable archive, are available
>via our web site at http://www.hrinet.org (click on "Listserv Lists")
>======================================================================
>
>
>"EMF <COH.org>" made the following annotations.
>---------------------------------------------------------------
>---------------
>SECURITY/CONFIDENTIALITY WARNING: This message and any
>attachments are intended solely for the individual or entity
>to which they are addressed. This communication may contain
>information that is privileged, confidential, or exempt from
>disclosure under applicable law (e.g., personal health
>information, research data, financial information). Because
>this e-mail has been sent without encryption, individuals
>other than the intended recipient may be able to view the
>information, forward it to others or tamper with the
>information without the knowledge or consent of the sender. If
>you are not the intended recipient, or the employee or person
>responsible for delivering the message to the intended
>recipient, any dissemination, distribution or copying of the
>communication is strictly prohibited. If you received the
>communication in error, please notify the sender immediately
>by replying to this message and deleting the message and any
>accompanying files from your system. If, due t!
> o the security risks, you do not wish to receive further
>communications via e-mail, please reply to this message and
>inform the sender that you do not wish to receive further
>e-mail from the sender.
>===============================================================
>===============
>
>
>======================================================================
> Instructions on how to use the RESADM-L Mailing List, including
> subscription information and a web-searchable archive, are available
> via our web site at http://www.hrinet.org (click on "Listserv Lists")
>======================================================================
>
>
======================================================================
Instructions on how to use the RESADM-L Mailing List, including
subscription information and a web-searchable archive, are available
via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================
